Neurocrine Biosciences Inc (NBIX) Com Stk NPV (CDI)

Sell:$152.60Buy:$174.76Price increased$1.20 (0.77%)

NASDAQ:Price increased0.19%
Market closed |
Prices delayed by at least 15 minutes
Sell:$152.60
Buy:$174.76
Change:Price increased$1.20 (0.77%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$152.60
Buy:$174.76
Change:Price increased$1.20 (0.77%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 May 2026
Kevin Charles GormanOther Level A
Sell
Regular sell transaction (market)
245,088$154.33$37,824,872.20511,293
15 May 2026
Richard F PopsIndependent Director
Sell
Option/Award related
15,000$157.65$2,364,760.5034,480
12 May 2026
Leslie V NorwalkIndependent Director
Sell
Regular sell transaction (market)
3,810$155.01$590,601.052,429
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
34,380$124.12$4,267,245.60551,293
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
2,901$124.12$360,072.12521,949
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
3,024$124.12$375,338.88519,473
13 February 2026
Kyle W. GanoPresident/CEO
Sell
Tax related
5,378$124.12$667,517.36150,815
13 February 2026
Kyle W. GanoPresident/CEO
Sell
Tax related
1,385$124.12$171,906.20146,225
13 February 2026
Kyle W. GanoPresident/CEO
Sell
Tax related
1,210$124.12$150,185.20145,044
13 February 2026
Eric S. BenevichChief Level Officer
Sell
Tax related
8,963$124.12$1,112,487.5663,190

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 May 2026
Kevin Charles GormanOther Level A
Sell
Regular sell transaction (market)
245,088$154.33$37,824,872.20511,293
7 August 2025
Kevin Charles GormanOther Level A
Sell
Option/Award related
106,322$126.41$13,440,280.97514,596
9 July 2025
Jude OnyiaChief Level Officer
Sell
Option/Award related
59,819$130.46$7,803,687.6518,289
16 January 2026
Kyle W. GanoPresident/CEO
Sell
Option/Award related
34,588$132.70$4,589,979.79140,407
13 February 2026
Kevin Charles GormanOther Level A
Sell
Tax related
34,380$124.12$4,267,245.60551,293

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.